Detroit to get mask factory with investment from Bangladesh company

The Dhaka-based conglomerate, which started selling the generic version of Gilead Sciences Inc.’s antiviral drug this month in the South Asian nation, will invest $20 million in the Detroit plant, …

( read original story …)